Human Flt-3/Flk-2 Antibody
R&D Systems, part of Bio-Techne | Catalog # MAB8122
Key Product Details
Species Reactivity
Validated:
Applications
Label
Antibody Source
Product Summary for Human Flt-3/Flk-2 Antibody
Immunogen
Met1-Asn541
Accession # P36888
Specificity
Clonality
Host
Isotype
Scientific Data Images for Human Flt-3/Flk-2 Antibody
Flt-3/Flk-2 in Human Liver.
Flt-3/Flk-2 was detected in immersion fixed paraffin-embedded sections of human liver using Mouse Anti-Human Flt-3/Flk-2 Monoclonal Antibody (Catalog # MAB8122) at 5 µg/mL for 1 hour at room temperature followed by incubation with the Anti-Mouse IgG VisUCyte™ HRP Polymer Antibody (VC001). Before incubation with the primary antibody, tissue was subjected to heat-induced epitope retrieval using Antigen Retrieval Reagent-Basic (CTS013). Tissue was stained using DAB (brown) and counterstained with hematoxylin (blue). Specific staining was localized to cytoplasm in Kupffer cells. Staining was performed using our protocol for IHC Staining with VisUCyte HRP Polymer Detection Reagents.Applications for Human Flt-3/Flk-2 Antibody
Immunohistochemistry
Sample: Immersion fixed paraffin-embedded sections of human liver
Formulation, Preparation, and Storage
Purification
Reconstitution
Formulation
Shipping
Stability & Storage
- 12 months from date of receipt, -20 to -70 °C as supplied.
- 1 month, 2 to 8 °C under sterile conditions after reconstitution.
- 6 months, -20 to -70 °C under sterile conditions after reconstitution.
Background: Flt-3/Flk-2
The Flt-3 (fms-like tyrosine kinase) receptor, also named Flk-2 (fetal liver kinase) and Stk-1(stem cell tyrosine kinase) is a member of the class III subfamily of receptor tyrosine kinases that also includes KIT, the receptor for SCF and FMS, the receptor for M-CSF. The extracellular region of these receptors contains five immunoglobulin-like domains and the intracellular region contains a split kinase domain. Human Flt-3 cDNA encodes a 993 amino acid (aa) residue type I membrane protein with a 26 aa residue signal peptide, a 515 aa extracellular domain with 10 potential N-linked glycosylation sites, a 21 aa residue transmembrane domain and a 431 aa residue cytoplasmic domain. Mouse Flt-3 has also been cloned and shown to share 85% amino acid sequence identity with human Flt-3. Flt-3 expression has been detected in various tissues, including placenta, gonads, and tissues of nervous and hematopoietic origin. Among hematopoietic cells, the expression of Flt-3 was found to be restricted to the highly enriched stem/progenitor cell populations. The ligand for Flt-3 (FL) has been identified to be a transmembrane protein with structural homology to M-CSF and SCF. Recombinant soluble Flt-3/Fc chimeric protein has been shown to bind FL with high affinity and is a potent FL antagonist.
References
- Rosnet, O. et al. (1996) Acta. Haemato. 95:218.
- Drexler, H.G. (1996) Leukemia 10:588.
Long Name
Alternate Names
Gene Symbol
UniProt
Additional Flt-3/Flk-2 Products
Product Documents for Human Flt-3/Flk-2 Antibody
Product Specific Notices for Human Flt-3/Flk-2 Antibody
For research use only